February 1, 2024
Parexel Appoints Susan R. Salka to Board of Directors
Ms. Salka brings more than 30 years of healthcare leadership and staffing expertise, including strong C-suite, financial and ESG expertise to advance the company’s Patients-first focus and growth initiatives.
January 10, 2024
Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance
Collaboration streamlines patient access to oncology clinical trials further expands Parexel's Site Alliance Network across Asia/Pacific